About 3,500 adults across 28 countries were enrolled in the trial, which started in 2019 and followed participants for an average of about 3 years
It is an analogue of Growth Hormone Releasing Hormone (GHRH), i.e., it behaves exactly like normally-occurring hormones that your body would produce to stimulate the release of growth hormone
To continue you confirm that you are qualified research professional aged 21 or older
The drug has been undergoing clinical trials for the treatment of hypoactive sexual desire disorder and erectile dysfunction
We use high-quality, sterile, medical-grade compounds, and your health history will be reviewed during a consultation to ensure it is the right therapy for you
It also promotes angiogenesis, or the formation of new blood vessels, allowing for increased oxygenation to the tissues